# Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
Canonical URL: https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-reports-first-quarter-2026-financial-results
Ticker: RPID
Company: Rapid Micro Biosystems
Source: Rapid Micro Biosystems
Published: 2026-05-13 20:26 EST
Original Source URL: https://investors.rapidmicrobio.com
## Summary

Reports first quarter 2026 total revenue of $8.0 million, representing 11% growth compared to the first quarter of 2025 Placed 6 Growth Direct systems in the first quarter 2026 compared to 3 systems in the first quarter of 2025 First quarter 2026 product revenue increased 36% year-over-year;

## Article Body
Reports first quarter 2026 total revenue of $8.0 million, representing 11% growth compared to the first quarter of 2025 Placed 6 Growth Direct systems in the first quarter 2026 compared to 3 systems in the first quarter of 2025 First quarter 2026 product revenue increased 36% year-over-year;
## Recent Company News
- 2026-05-19 01:55 EST — [Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-announces-pricing-of-up-to-approximately-32-million-underwritten-offering) — Source: Rapid Micro Biosystems
- 2026-05-13 20:26 EST — [Rapid Micro Biosystems Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-reports-first-quarter-2026-financial-results) — Source: Rapid Micro Biosystems
- 2026-05-06 20:15 EST — [Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-to-announce-first-quarter-2026-financial-results-on-may-13-2026) — Source: Rapid Micro Biosystems
- 2026-03-12 11:00 EST — [Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-reports-record-fourth-quarter-and-full-year-2025-financial-results-and-provides-2026-guidance) — Source: Rapid Micro Biosystems
- 2026-03-12 10:30 EST — [Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-announces-follow-on-multi-system-order-from-samsung-biologics-to-expand-deployment-of-growth-directr-platform) — Source: Rapid Micro Biosystems
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)